Tubular Structure Based on Hyaluronic Acid Derivatives for the Preparation of Vascular and Urethral Graft

• US 20080095818A1
• Filed: 10/27/2005
• Published: 04/24/2008
• Est. Priority Date: 10/27/2004
• Status: Abandoned Application

• Current Assignee: Fidia Advanced Biopolymers S.R.L. (Anika Therapeutics Incorporated)
• Original Assignee: Fidia Advanced Biopolymers S.R.L. (Anika Therapeutics Incorporated)
• Inventors: Abatangelo, Giovanni, Callegaro, Lanfranco
• Application Number:
  US11/666,200
• Publication Number:
  US 20080095818A1
• Time in Patent Office: Days
• US Class Current: 424/423
• CPC Class Codes: A61L 27/20 Polysaccharides
• CPC Class Codes: A61L 27/507 for artificial blood vessels apparatus for applying cells on a blood vessel prosthesis A61F2/062
• CPC Class Codes: C08L 5/08 Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Abstract

Tubular structure, whose wall has an unbroken surface consisting essentially of at least one HA derivative and optionally a further polymer of natural, synthetic or semisynthetic origin. Said tubular structure, which is prepared with a very simple process, is used for the preparation of vascular and urethral grafts.

Claims

1. A tubular structure suitable for use as vascular or urethral grafts, whose wall has an unbroken surface, consisting essentially of at least one hyaluronic acid derivative, optionally in association with at least one other polymer of natural synthetic or semisynthetic origin.

2. The tubular structure according to claim 1, consisting essentially of at least one hyaluronic acid derivative.

3. Tubular structure according to claim 1 wherein the hyaluronic acid derivative is chosen from a group consisting of:

hyaluronic acid esters with alcohols of the aliphatic, araliphatic, cycloaliphatic, aromatic, cyclic and heterocyclic series;

amides of hyaluronic acid with amines of the aliphatic, araliphatic, cycloaliphatic, aromatic, cyclic and heterocyclic series;

deacetylated hyaluronic acid;

O-sulphated hyaluronic acid;

percarboxylated hyaluronic acid, and mixtures thereof.

4. The tubular structure according to claim 3 wherein the hyaluronic acid derivative is an ester.

5. The tubular structure according to claim 4 wherein the hyaluronic acid ester is preferably the benzyl ester with a degree of esterification of between 75 and 100%.

6. The tubular structure according to claim 5, wherein the hyaluronic benzyl ester has an esterification degree of 100%.

7. The tubular structure according to claim 1, wherein said further optional polymer is of natural origin and it is selected from the group consisting of:

collagen, elastin, coprecipitates of collagen and glycosaminoglycans, cellulose, polysaccharides in the form of a gel, selected from chitin, chitosan, pectin or pectic acid, agar, agarose, xanthane gum, gellan, alginic acid or alginates, polymannan or polyglycans, polyamides, natural gums.

8. The tubular structure according to claim 1, wherein said further optional polymer is of semisynthetic origin and it is selected from the group consisting of:

collagen cross-linked with agents selected from aldehydes or the precursors thereof, dicarboxylic acid or the halides thereof and diamines,

derivatives of;

cellulose, alginic acid, starch, chitin, chitosan, gellan, xanthane, pectin or pectic acid, polyglicans, polymannan, agar, agarose, natural gums, glycosaminoglycans.

9. The tubular structure according to claim 1, wherein said further polymer is of synthetic origin and it is selected from polylactic and polyglycolic acids, copolymers and derivatives thereof, polydioxane and polyphosphazene resins.

10. The tubular structure according to claim 1, having a weight ratio of hyaluronic acid derivative/further optional polymer, in case the latter present, comprised between:

95;

5 and 60;

40.

11. The tubular structure according to claim 1, further containing at least one pharmacologically and/or biologically active substance.

12. A vascular graft comprising the tubular structure according to claim 1.

13. An urethral graft comprising the tubular structure according to claim 1.

14. A process for preparing the tubular structure according to claim 1 comprising the following steps:

(I) dissolving the HA derivative in DMSO and optionally the second further polymer;

(II) coating with the solution thus obtained rotating steel cylinders of varying diameters;

(III) coagulating the solution adhered to the cylinder in an ethanol bath;

(IV) removing from the cylindrical support, washing with ethanol and air blow drying the tubular structure,